In experimental models of cerebral cavernous malformations (CCM), deletion of programmed cell death 10 (CCM3), a molecular regulator of cellular apoptosis, enhances VEGFR3 expression and ERK1/2 activation in LECs, leading to hyperplastic lymphatic development [65]. Here, MAPK3 is linked to cerebral cavernous malformation.